Appendix D to Part 40 Appendix D to Part 40—DOT Drug Testing Semi-Annual Laboratory Report to Employers

LinkThe tofollowing anitems amendmentare publishedrequired aton 88each FRlaboratory 27651,report:
Reporting MayPeriod: 2,(inclusive 2023.dates)
LinkLaboratory toIdentification: an(name amendmentand publishedaddress)
Employer atIdentification: 88(name; FRmay 27652,include MayBilling 2,Code 2023.or ID code)
Mail,C/TPA fax,Identification: or(where submitapplicable; electronicallyname to:and address)
UA.S. DepartmentUrine ofSpecimens
1. Transportation,Urine OfficeSpecimen ofResults DrugReported and(Total AlcoholNumber) PolicyBy andTest Compliance,Reason
(a) W62Pre-300,employment 1200(number)
(b) NewPost-Accident Jersey(number)
(c) AvenueRandom SE.,(number)
(d) Washington,Reasonable DCSuspicion/Cause 20590, Fax: (202number)
(e) 366Return-3897.to-Duty (number)
Submit(f) Electronically: https://www.transportation.gov/content/splitFollow-specimen-cancellation-notification-49-cfr-part-40187-appendix-dup (number)
The(g) followingType itemsof areTest requiredNot Noted on eachCCF report:(number)
12. MROUrine name,Specimens address,Reported
(a) phoneNegative (number,)
(b) Negative and faxDilute (number.)
23. CollectionUrine siteSpecimens name,Reported address,as andRejected phonefor Testing (Total Number) by Reason
(a) Fatal flaw (number.)
3.(b) DateUncorrected ofFlaw collection.(number)
4. SpecimenUrine I.D.Specimens number.Reported as Positive (Total Number) by Drug
5.(a) LaboratoryMarijuana accessionMetabolite (number.)
6.(b) PrimaryCocaine specimenMetabolite laboratory(number)
(c) name,Opioids address,(number)
(1) andCodeine phone (number.)
7.(2) DateMorphine result(number)
(3) reported6-AM or(number)
(4) certifiedHydrocodone by(number)
(5) primaryHydromorphone laboratory.(number)
8.(6) SplitOxycodone specimen(number)
(7) laboratoryOxymorphone name,(number)
(d) address,Phencyclidine and(number)
(e) phoneAmphetamines (number.)
9.(1) DateAmphetamine split(number)
(2) specimenMethamphetamine result(number)
(3) reportedMDMA or(number)
(4) certifiedMDA by(number)
5. splitUrine specimenAdulterated laboratory(Number)
6. Urine Substituted (Number)
107. PrimaryUrine specimenInvalid resultsResult (eNumber)
B.g Oral Fluid Specimens
1., nameOral ofFluid drug,Specimen adulterantResults Reported (Total Number) inby theTest primaryReason
(a) specimen.Pre-employment (number)
11.(b) ReasonPost-Accident for(number)
(c) splitRandom specimen(number)
(d) failureReasonable Suspicion/Cause (number)
(e) Return-to-reconfirmDuty result(number)
(f) Follow-up (e.number)
(g.,) drugType orof adulterantTest notNot present,Noted specimenon invalid,CCF split(number)
2. notOral collected,Fluid insufficientSpecimens volumeReported
(a). Negative (number)
12(b) Negative and Dilute (number)
3. ActionsOral takenFluid Specimens Reported as Rejected for Testing (Total Number) by theReason
(a) MROFatal flaw (enumber)
(b) Uncorrected Flaw (number)
4.g., notifiedOral employerFluid ofSpecimens failureReported toas reconfirmPositive (Total Number) by Drug
(a) Marijuana (number)
(b) Cocaine and/or requirementCocaine forMetabolite recollection(number).
13.(c) AdditionalOpioids information(number)
(1) explainingCodeine the(number)
(2) reasonMorphine for(number)
(3) cancellation.6-AM (number)
14(4) Hydrocodone (number)
(5) Hydromorphone (number)
(6) Oxycodone (number)
(7) Oxymorphone (number)
(d) Phencyclidine (number)
(e) Amphetamines (number)
(1) Amphetamine (number)
(2) Methamphetamine (number)
(3) MDMA (number)
(4) MDA (number)
5. NameOral ofFluid individualAdulterated submitting(Number)
6. theOral reportFluid Substituted (ifNumber)
7. notOral theFluid MROInvalid Result (Number)
[8288 FR 5224727651, Nov.May 132, 20172023]